Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial

NCT00169832 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

193

Enrollment

OTHER

Sponsor class

Conditions

Diabetes
Coronary Artery Bypass Grafting

Interventions

DRUG: Rosiglitazone or placebo

Sponsor

Laval University

Collaborators

[object Object]